Table 1

Adverse prognostic factors for event free survival in Wilms’ tumour

ClinicalMolecular
Stage IVAllele loss at 1p and/or 16q
Anaplastic histological subtypep53 mutation
Lymph node metastases
Insufficient number of lymph nodes sampled at nephrectomy28